Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applovin
APP
|
+$1.56B |
| 2 |
Amazon
AMZN
|
+$1.34B |
| 3 |
Eli Lilly
LLY
|
+$1.26B |
| 4 |
NVIDIA
NVDA
|
+$1.08B |
| 5 |
Chevron
CVX
|
+$1.03B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HES
Hess
HES
|
+$964M |
| 2 |
ANSS
Ansys
ANSS
|
+$924M |
| 3 |
Johnson & Johnson
JNJ
|
+$753M |
| 4 |
JNPR
Juniper Networks
JNPR
|
+$418M |
| 5 |
American Express
AXP
|
+$253M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.52% |
| 2 | Financials | 13.57% |
| 3 | Consumer Discretionary | 10.61% |
| 4 | Communication Services | 9.71% |
| 5 | Healthcare | 9.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2276
Bausch Health
BHC
$2.37B
| $12.6M | ﹤0.01% |
1,451,647
+611,229
| +73% | +$4.18M |
|
|
ESPR
2277
DELISTED
Esperion Therapeutics
ESPR
| $12.6M | ﹤0.01% |
4,751,396
+167,408
| +4% | +$324K |
|
2278
Cerence
CRNC
$389M
| $12.6M | ﹤0.01% |
1,008,587
-40,387
| -4% | -$414K |
|
2279
Mission Produce
AVO
$1.15B
| $12.6M | ﹤0.01% |
1,044,854
-138,354
| -12% | -$1.71M |
|
2280
Domo
DOMO
$187M
| $12.5M | ﹤0.01% |
791,799
-30,221
| -4% | -$468K |
|
2281
Olema Pharmaceuticals
OLMA
$920M
| $12.5M | ﹤0.01% |
1,276,005
-50,118
| -4% | -$301K |
|
|
CCRN
2282
DELISTED
Cross Country Healthcare
CCRN
| $12.5M | ﹤0.01% |
878,887
+50,144
| +6% | +$662K |
|
|
PKST
2283
DELISTED
Peakstone Realty Trust
PKST
| $12.5M | ﹤0.01% |
951,165
-15,113
| -2% | -$201K |
|
2284
Eton Pharmaceutcials
ETON
$1.12B
| $12.5M | ﹤0.01% |
574,030
-18,835
| -3% | -$313K |
|
2285
Colliers International
CIGI
$5.41B
| $12.5M | ﹤0.01% |
79,619
+5,474
| +7% | +$842K |
|
2286
MetroCity Bankshares
MCBS
$1.05B
| $12.4M | ﹤0.01% |
448,555
+4,625
| +1% | +$134K |
|
|
DAWN
2287
DELISTED
Day One Biopharmaceuticals
DAWN
| $12.4M | ﹤0.01% |
1,761,264
+48,835
| +3% | +$336K |
|
|
NLOP
2288
Net Lease Office Properties
NLOP
$173M
| $12.4M | ﹤0.01% |
417,507
-2,874
| -0.7% | -$90.2K |
|
2289
Bloomin' Brands
BLMN
$924M
| $12.4M | ﹤0.01% |
1,726,325
-211,412
| -11% | -$1.7M |
|
2290
Varex Imaging
VREX
$780M
| $12.4M | ﹤0.01% |
998,037
+8,980
| +0.9% | +$89K |
|
2291
Zevra Therapeutics
ZVRA
$664M
| $12.4M | ﹤0.01% |
1,300,340
+57,954
| +5% | +$581K |
|
2292
Shore Bancshares
SHBI
$799M
| $12.4M | ﹤0.01% |
753,105
+3,778
| +0.5% | +$62.2K |
|
2293
Peapack-Gladstone Financial
PGC
$822M
| $12.3M | ﹤0.01% |
447,261
+68,080
| +18% | +$1.91M |
|
|
AVNS
2294
DELISTED
Avanos Medical
AVNS
| $12.3M | ﹤0.01% |
1,067,524
-6,525
| -0.6% | -$76.4K |
|
2295
Gossamer Bio
GOSS
$83.3M
| $12.3M | ﹤0.01% |
4,689,531
+134,451
| +3% | +$296K |
|
2296
AdvanSix
ASIX
$446M
| $12.3M | ﹤0.01% |
635,200
+2,688
| +0.4% | +$56.5K |
|
|
MAZE
2297
Maze Therapeutics
MAZE
$1.54B
| $12.3M | ﹤0.01% |
473,549
+242,312
| +105% | +$4.09M |
|
2298
Shutterstock
SSTK
$217M
| $12.3M | ﹤0.01% |
588,552
+5,434
| +0.9% | +$111K |
|
2299
Mitek Systems
MITK
$853M
| $12.2M | ﹤0.01% |
1,252,737
+159,137
| +15% | +$1.56M |
|
2300
Southern Missouri Bancorp
SMBC
$850M
| $12.2M | ﹤0.01% |
232,630
+1,966
| +0.9% | +$110K |
|
Similar funds
Geode Capital Management's Q3 2025 Portfolio in Review
As of Q3 2025, Geode Capital Management held 4,592 positions worth $1.57T, up 9.9% from $1.43T the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Geode Capital Management's Q3 2025 filing shows 148 new, 2,907 increased, 1,130 reduced and 119 closed positions. Its largest new stake was Paramount Skydance Corp: 8,343,504 shares worth $158M. The largest sale was Hess, an estimated $964M.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Financials and Consumer Discretionary.
- Geode Capital Management's largest Q3 2025 buy was Paramount Skydance Corp: 8,343,504 shares worth $158M.
- Geode Capital Management added most to Applovin in Q3 2025, an estimated $1.56B increase.
- Geode Capital Management's biggest Q3 2025 reduction was Johnson & Johnson, cutting an estimated $753M.
- Geode Capital Management fully exited Hess in Q3 2025, selling an estimated $964M.
- Geode Capital Management's ten largest holdings make up 34% of its $1.57T portfolio in Q3 2025.
- Geode Capital Management opened 148 new positions and closed 119 in Q3 2025.
- Geode Capital Management's portfolio value rose 9.9% quarter-over-quarter to $1.57T.
Based on Geode Capital Management's 13F filing for Q3 2025, filed 12 Nov 2025.